A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering ...

From an early age, Dr. Burke Soffe knew the traditional path of life wasn't for him. As the fifth of seven children, Soffe ...

F ourteen candidates are seeking four seats on the Wichita school board. They are focused on issues ranging from student ...